What is NDC 16571-883?

16571-883 is the product NDC for Allopurinol, Allopurinol 100 mg/1 tablet, listed with the FDA by Rising Pharma Holdings, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.

Rising Pharma Holdings, Inc., NDC labeler code 16571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Allopurinol?

166 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Allopurinol NDC 16571-883 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)16571-883Labeler and product segments. Claims need a package NDC.

Product NDC at billing width16571-0883Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
16571-883-01	16571088301	100 TABLET in 1 BOTTLE (16571-883-01)Marketed from Sep 21, 2023
16571-883-09	16571088309	90 TABLET in 1 BOTTLE (16571-883-09)Marketed from Sep 21, 2023
16571-883-10	16571088310	1000 TABLET in 1 BOTTLE (16571-883-10)Marketed from Sep 21, 2023
16571-883-50	16571088350	500 TABLET in 1 BOTTLE (16571-883-50)Marketed from Sep 21, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Allopurinol
Generic name (nonproprietary): allopurinol
Active ingredients: Allopurinol — 100 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Rising Pharma Holdings, Inc.NDC labeler code 16571
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 016084
Marketing start: Sep 21, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Xanthine Oxidase Inhibitors (Mechanism)
Identifiers: Product ID 16571-883_14a0ad9d-4145-4869-9d8d-747e5d7bfb44SPL ID 14a0ad9d-4145-4869-9d8d-747e5d7bfb44SPL set ID 30ad5ba2-1cef-4933-b104-0597f6a2aaa2RxCUI 197319, 197320, 245422UNII 63CZ7GJN5I
Pharmacologic class: Xanthine Oxidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416571088301 followed by a unit qualifier and the quantity

Package 16571-0883-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 21, 2026.

Indications (excerpt from the label)

Allopurinol tablet is indicated for: The management of adults with signs and symptoms of primary or secondary gout (acute attacks, tophi, joint destruction, uric acid lithiasis, and/or nephropathy) The management of adult and pediatric patients with leukemia, lymphoma and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels The management of adult patients with recurrent calcium oxalate calculi whose daily uric acid excretion exceeds 800 mg/day in male patients and 750 mg/day in female patients, despite lifestyle changes (such as reduction of dietary sodium, non-dairy animal protein, oxylate rich foods, refined sugars and inc…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 16571-883

What is NDC 16571-883?: 16571-883 is the product NDC for Allopurinol, Allopurinol 100 mg/1 tablet, listed with the FDA by Rising Pharma Holdings, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Allopurinol.
What is the active ingredient?: Allopurinol.
Who is the labeler?: Rising Pharma Holdings, Inc., NDC labeler code 16571. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Allopurinol?: 166 other product NDCs are listed under this name. See all Allopurinol NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Allopurinol NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Allopurinol	Allopurinol 300 mg/1	TabletOral	Cardinal Health 107, LLC	55154-0282	55154-0282-00
Allopurinol	Allopurinol 300 mg/1	TabletOral	REMEDYREPACK INC.	70518-4693	70518-4693-00
Allopurinol	Allopurinol 100 mg/1	TabletOral	Safecor Health, LLC	48433-002	48433-0002-20
Allopurinol	Allopurinol 300 mg/1	TabletOral	Safecor Health, LLC	48433-003	48433-0003-20
Allopurinol	Allopurinol 300 mg/1	TabletOral	Coupler LLC	67046-1658	67046-1658-03
Allopurinol	Allopurinol 300 mg/1	TabletOral	REMEDYREPACK INC.	70518-4556	70518-4556-00
Allopurinol	Allopurinol 300 mg/1	TabletOral	Northwind Health Company, LLC	82868-099	82868-0099-3082868-0099-90
Allopurinol	Allopurinol 100 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	53401-019	53401-0019-6053401-0019-80
Allopurinol	Allopurinol 300 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	53401-025	53401-0025-60
Allopurinol	Allopurinol 100 mg/1	TabletOral	XLCare Pharmaceuticals Inc.	72865-303	72865-0303-0172865-0303-0572865-0303-10+1 more

All 167 Allopurinol NDCs

Other NDCs under NDA 016084

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 016084
Product	Strength	Form · route	Labeler	Product NDC
Allopurinol	Allopurinol 200 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-884
Allopurinol	Allopurinol 300 mg/1	TabletOral	Rising Pharma Holdings, Inc.	16571-885
Allopurinol	Allopurinol 300 mg/1	TabletOral	Coupler LLC	67046-1514